IDH1 and central nervous system cancer: Also, serum 2HG concentrations were in a similar range for gliomas with IDH1/2 mutations (33–283 ng/mL), and these were no different from those for patients with gliomas with wt IDH1/2 (35–277 ng/mL) (49).